Doris Parnes works at the Molecular Hematology Laboratory, at Israel’s Rabin Medical Center, engaging in the diagnosis of hematological disorders and patients follow up.
She came to New York, through the Rabin Medical exchange program with the goal to learn about new sequencing technologies and implement new molecular tests in her laboratory back in Israel.
HOW THE RABIN EXCHANGE FELLOWSHIP EXPANDED HER KNOWLEDGE IN THE FIELD OF MOLECULAR HEMATOLOGY
“The generous support of AFRMC’S donors, in particular the Trobman family, enabled me to get familiar with new powerful technologies. I now have a better understanding about the technical requirements and preparations to be done before establishing them in our institution at Rabin Medical Center, and the tremendous clinical information that they can potentially provide.”
THE IMPORTANCE OF INTERNATIONAL MEDICAL RELATIONSHIPS TO THE FUTURE OF MEDICINE & RESEARCH
“The AFRMC Rabin Medical Exchange Fellowship program allow doctors the opportunity to learn from other medical institutions, to get familiar with new theologies and to sow the seedsfor future collaborations. My fellowship has given me the chance to be exposed to the most up to date developments in the field of molecular diagnostics and to acquire knowledge and experience from the best in the field.”
“Memorial Sloan Kettering Cancer Center has a well-known International Observership program. I met another international fellows, a young doctor from Iran. I was very surprised when he approached me to say that the people in Iran actually have very warm feelings towards Israel and it is not at all as it seems on television and the media. Our conversation left us both quite optimistic about the possible future relations between both countries. We ended our meeting with hopes for future collaborations between our institutions.”
WHAT DORIS LEARNED AT MSKCC
“I was amazed by the improvements in current tests which the pathology lab at MSKCC is going to adapt at the very near future. These tests will be more sensitive and accurate than ever and much more informative to the physician regarding the patients disease status.”